Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 964687, 4 pages
http://dx.doi.org/10.1155/2015/964687
Case Report

Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid

1Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9038 Tromsø, Norway
3Department of Pathology, Nordland Hospital, 8092 Bodø, Norway
4Department of Pulmonology, Nordland Hospital, 8092 Bodø, Norway

Received 15 June 2015; Accepted 27 July 2015

Academic Editor: Jose I. Mayordomo

Copyright © 2015 Carsten Nieder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Demaria, B. Ng, M. L. Devitt et al., “Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated,” International Journal of Radiation Oncology, Biology, Physics, vol. 58, no. 3, pp. 862–870, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Shiraishi, Y. Ishiwata, K. Nakagawa et al., “Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1α,” Clinical Cancer Research, vol. 14, no. 4, pp. 1159–1166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Rödel, B. Frey, G. Multhoff, and U. Gaipl, “Contribution of the immune system to bystander and non-targeted effects of ionizing radiation,” Cancer Letters, vol. 356, no. 1, pp. 105–113, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Ong, R. Goldacre, U. Hoang, R. Sinclair, and M. Goldacre, “Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999–2011,” Archives of Dermatological Research, vol. 306, no. 1, pp. 75–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kunisawa, K. Yamashita, H. Ikai, T. Otsubo, and Y. Imanaka, “Survival analyses of postoperative lung cancer patients: an investigation using Japanese administrative data,” SpringerPlus, vol. 3, article 217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. B. van Oorschot, B. Assenbrunner, M. Schuler, G. Beckmann, and M. Flentje, “Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer,” Strahlentherapie und Onkologie, vol. 190, no. 3, pp. 270–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Schröder, M. Ivo, and A. Buchali, “Does high-dose radiotherapy benefit palliative lung cancer patients?: an intradepartmental comparison of two dose regimens,” Strahlentherapie und Onkologie, vol. 189, no. 9, pp. 771–776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. B. Golden, S. Demaria, P. B. Schiff, A. Chachoua, and S. C. Formenti, “An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer,” Cancer Immunology Research, vol. 1, no. 6, pp. 365–372, 2013. View at Publisher · View at Google Scholar
  9. U. S. Gaipl, G. Multhoff, H. Scheithauer et al., “Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy,” Immunotherapy, vol. 6, no. 5, pp. 597–610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Sharon, M.-Y. Polley, M. B. Bernstein, and M. Ahmed, “Immunotherapy and radiation therapy: considerations for successfully combining radiation into the paradigm of immuno-oncology drug development,” Radiation Research, vol. 182, no. 2, pp. 252–257, 2014. View at Publisher · View at Google Scholar · View at Scopus